[Levofloxacin/dexamethasone (inflammation and infection associated with cataract surgery) - Benefit assessment according to §35a Social Code Book V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003866
Original Title: Levofloxacin/Dexamethason (Entzuendungen und Infektionen nach Kataraktoperationen)
Project Status: Completed
Year Published: 2021
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Cataract Extraction
  • Surgical Wound Infection
  • Dexamethasone
  • Levofloxacin
  • Anti-Bacterial Agents
  • Postoperative Complications
  • Cataract
  • Levofloxacin
  • Dexamethasone
  • Surgical Wound Infection
  • Cataract
  • Benefit Assessment
  • NCT 03739528
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.